Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

被引:0
|
作者
Dekeyser, Catherine [1 ]
De Kesel, Pieter [2 ]
Cambron, Melissa [3 ,4 ]
Vanopdenbosch, Ludo [3 ]
Van Hijfte, Liesbeth [1 ]
Vercammen, Martine [5 ,6 ]
Laureys, Guy [1 ]
机构
[1] Ghent Univ Hosp, Dept Neurol, Ghent, Belgium
[2] Ghent Univ Hosp, Dept Lab Med, Ghent, Belgium
[3] Dept Neurol, AZ Sint Jan Brugge, Brugge, Belgium
[4] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium
[5] Algemeen Ziekenhuis AZ Sint Jan Brugge, Dept Lab Med, Brugge, Belgium
[6] Vrije Univ Brussel, Basic Biomed Sci, Brussels, Belgium
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
multiple sclerosis; kappa free light chains; kappa FLC index; kappa IgG index; CSF kappa FLC/IgG ratio; Freelite (R)-Optilite versus N Latex (R)-BNII; BIOLOGICAL VARIATION; PERFORMANCE; BIOMARKER;
D O I
10.3389/fimmu.2024.1385231
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Cerebrospinal fluid (CSF) kappa free light chain (kappa FLC) measures gained increasing interest as diagnostic markers in multiple sclerosis (MS). However, the lack of studies comparing assay-dependent diagnostic cutoff values hinders their use in clinical practice. Additionally, the optimal kappa FLC parameter for identifying MS remains a subject of ongoing debate. Objectives: The aim of this study was to compare same-sample diagnostic accuracies of the kappa FLC index, kappa IgG index, CSF kappa FLC/IgG ratio, and isolated CSF kappa FLC (iCSF-kappa FLC) between two reference centers using different methods. Methods: Paired serum and CSF samples were analyzed for kappa FLC and albumin concentrations by Freelite (R)-Optilite (Sint-Jan Bruges hospital) and N Latex (R)-BNII (Ghent University hospital). Diagnostic performance to differentiate MS from controls was assessed using ROC curve analysis. Results: A total of 263 participants were included (MS, n = 80). Optimal diagnostic cutoff values for the kappa FLC index (Freelite (R)-Optilite: 7.7; N Latex (R)-BNII: 4.71), kappa IgG index (Freelite (R)-Optilite: 14.15, N Latex (R)-BNII: 12.19), and CSF kappa FLC/IgG ratio (Freelite (R)-Optilite: 2.27; N Latex (R)-BNII: 1.44) differed between the two methods. Sensitivities related to optimal cutoff values were 89.9% (Freelite (R)-Optilite) versus 94.6% (N Latex (R)-BNII) for the kappa FLC index, 91% (Freelite (R)-Optilite) versus 92.2% (N Latex (R)-BNII) for the kappa IgG index, and 81.3% (Freelite (R)-Optilite) versus 91.4% (N Latex (R)-BNII) for the CSF kappa FLC/IgG ratio. However, for iCSF-kappa FLC, optimal diagnostic cutoff values (0.36 mg/L) and related specificities (81.8%) were identical with a related diagnostic sensitivity of 89.9% for Freelite (R)-Optilite and 90.5% for N Latex (R)-BNII. The diagnostic performance of the kappa FLC index [area under the curve (AUC) Freelite (R)-Optilite: 0.924; N Latex (R)-BNII: 0.962] and kappa IgG index (AUC Freelite (R)-Optilite: 0.929; N Latex (R)-BNII: 0.961) was superior compared to CSF oligoclonal bands (AUC: 0.898, sensitivity: 83.8%, specificity: 95.9%). Conclusions: The kappa FLC index and the kappa IgG index seem to be excellent markers for identifying MS, irrespective of the method used for kappa FLC quantification. Based on the AUC, they appear to be the measures of choice. For all measures, optimal cutoff values differed between methods except for iCSF-kappa FLC. iCSF-kappa FLC might therefore serve as a method-independent, more cost-efficient, initial screening measure for MS. These findings are particularly relevant for clinical practice given the potential future implementation of intrathecal kappa FLC synthesis in MS diagnostic criteria and for future multicentre studies pooling data on kappa FLC measures.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Kappa free light chains in cerebrospinal fluid for the diagnosis of multiple sclerosis
    Trapiello Fernandez, W.
    Rodriguez Perez, G.
    Losa Rodriguez, R.
    Aguirre Gervas, B.
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S613 - S613
  • [2] Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
    Hegen, Harald
    Arrambide, Georgina
    Gnanapavan, Sharmilee
    Kaplan, Batia
    Khalil, Michael
    Saadeh, Ruba
    Teunissen, Charlotte
    Tumani, Hayrettin
    Villar, Luisa Maria
    Willrich, Maria Alice, V
    Zetterberg, Henrik
    Deisenhammer, Florian
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (02) : 182 - 195
  • [3] Cerebrospinal fluid kappa free light chains and IgM index for diagnosis and prognosis in multiple sclerosis
    Gil-Perotin, S.
    Castillo, J.
    Laiz, B.
    Cabello, J.
    Solis, L.
    Alcala, C.
    Quintanilla, C.
    Perez-Miralles, F.
    Casanova, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 528 - 528
  • [4] Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis
    Christiansen, Mikael
    Gjelstrup, Mikkel Carstensen
    Stilund, Morten
    Christensen, Tove
    Petersen, Thor
    Moller, Holger Jon
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2019, 57 (02) : 210 - 220
  • [5] Examination of free kappa light chains in the cerebrospinal fluid and serum of multiple sclerosis patients
    Kalistova, H
    Havrdová, E
    Rasová, K
    Tyblová, M
    Zeman, D
    Benáková, H
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2005, 68 (02) : 90 - +
  • [6] Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
    Harald Hegen
    Klaus Berek
    Florian Deisenhammer
    [J]. Wiener Medizinische Wochenschrift, 2022, 172 : 337 - 345
  • [7] Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis
    Hegen, Harald
    Walde, Janette
    Berek, Klaus
    Arrambide, Georgina
    Gnanapavan, Sharmilee
    Kaplan, Batia
    Khalil, Michael
    Saadeh, Ruba
    Teunissen, Charlotte
    Tumani, Hayrettin
    Villar, Luisa M.
    Willrich, Maria Alice, V
    Zetterberg, Henrik
    Deisenhammer, Florian
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (02) : 169 - 181
  • [8] Kappa free light chains in multiple sclerosis - diagnostic accuracy and comparison with other markers
    Cierny, D.
    Kantorova, E.
    Skerenova, M.
    Kurca, E.
    Lehotsky, J.
    Dobrota, D.
    [J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2021, 84 (04) : 353 - 360
  • [9] Kappa free light chains in cerebrospinal fluid predict early multiple sclerosis disease activity
    Hegen, H.
    Berek, K.
    Bsteh, G.
    Auer, M.
    Di Pauli, F.
    Grams, A.
    Milosavljevic, D.
    Poskaite, P.
    Schnabl, C.
    Wurth, S.
    Zinganell, A.
    Berger, T.
    Walde, J.
    Deisenhammer, F.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 505 - 506
  • [10] Diagnostic utility of kappa free light chains in multiple sclerosis
    Kaplan, Batia
    Ganelin-Cohen, Esther
    Golderman, Sizilia
    Livneh, Avi
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (04) : 277 - 279